Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer

Last updated: July 23, 2024
Sponsor: Helse Stavanger HF
Overall Status: Active - Recruiting

Phase

N/A

Condition

Colon Cancer; Rectal Cancer

Rectal Cancer

Colon Cancer

Treatment

open and laparoscopic surgery

Clinical Study ID

NCT01762813
29034/2012
  • Ages > 18
  • All Genders

Study Summary

  • A prospective, observational study on clinical outcomes of surgical management of primary and metastatic colorectal cancer

  • Prospective collection of tissues to explore potential biomarkers in blood and/or primary or secondary cancers and/or normal colon

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosis of colorectal cancer, primary or metastatic (liver), with a treatmentintention of planned curative surgery

  • Informed consent to participate

  • Age ≥18

Exclusion

Exclusion Criteria:

  • failure to provide written informed consent

Study Design

Total Participants: 1200
Treatment Group(s): 1
Primary Treatment: open and laparoscopic surgery
Phase:
Study Start date:
January 01, 2013
Estimated Completion Date:
December 31, 2027

Study Description

Prospective project in collecting and assessing clinical outcomes data related to molecular profiling of tumors based on cancer primary or metastatic tissue or tissue from peripheral blood samples. As a future part of the project will be collected patient reported outcomes (PROs) for assessing clinical outcomes in relation to clinical pathways, patient reported results, as well as tumor profiling by molecular methods.

Connect with a study center

  • Stavanger University Hospital

    Stavanger, 4068
    Norway

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.